This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-06-4610v1 67/6/2420    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bentires-Alj, M. Articles by Neel, B. G. Search for Related Content PubMed PubMed Citation Articles by Bentires-Alj, M. Articles by Neel, B. G.

Protein-Tyrosine Phosphatase 1B Is Required for HER2/Neu–Induced Breast Cancer

Cancer Biology Program, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Requests for reprints: Mohamed Bentires-Alj, Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, CH-4058 Basel, Switzerland. Phone: 41-61-69-74048; Fax: 41-61-697-3976; E-mail: bentires{at}fmi.ch.

The protein-tyrosine phosphatase 1B (PTP1B; PTPN1) is an important regulator of mammalian metabolism and also helps control signaling by growth factors, cytokines, and extracellular matrix. Gene knockout studies in mice established PTP1B as a key negative regulator of the insulin and leptin receptors. Experiments using PTP1B^–/– fibroblast lines, dominant-negative mutants, or small interfering RNAs indicate that PTP1B contributes to dephosphorylation of the epidermal growth factor receptor and platelet-derived growth factor receptors as well. However, PTP1B also may have some positive (signal enhancing) roles downstream of some growth factor receptors and integrins. Previous studies indicated that PTP1B is overexpressed in a significant subset of breast and ovarian cancers, especially in those overexpressing HER2/Neu (HER2⁺ tumors). However, experiments using tissue culture cells yield conflicting results on the effects of PTP1B in HER2 signaling, leaving the consequences of PTP1B overexpression for breast carcinogenesis unclear. To determine how PTP1B deficiency affects HER2-evoked breast tumorigenesis, we generated mouse mammary tumor virus (MMTV)–NeuNT transgenic mice lacking one or both alleles of PTP1B. Although heterozygous loss of PTP1B has no effect on tumorigenesis, homozygous PTP1B deficiency dramatically delays or prevents the onset of MMTV-NeuNT–evoked breast tumors. The effects of PTP1B deficiency correlate with defective extracellular signal-regulated kinase activation in preneoplastic mammary glands from compound mutant mice. In contrast, PTP1B deficiency has no effect on MMTV-polyoma middle T tumorigenesis. Our data raise the possibility that PTP1B inhibitors may be chemopreventative for some forms of breast cancer. [Cancer Res 2007;67(6):2420–4]

This article has been cited by other articles:

				M. Stuible, N. Dube, and M. L. Tremblay PTP1B Regulates Cortactin Tyrosine Phosphorylation by Targeting Tyr446 J. Biol. Chem., June 6, 2008; 283(23): 15740 - 15746. [Abstract] [Full Text] [PDF]

				C. L. Cortesio, K. T. Chan, B. J. Perrin, N. O. Burton, S. Zhang, Z.-Y. Zhang, and A. Huttenlocher Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion J. Cell Biol., March 5, 2008; 180(5): 957 - 971. [Abstract] [Full Text] [PDF]

				N. K. Prasad, M. Tandon, S. Badve, P. W. Snyder, and H. Nakshatri Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover Carcinogenesis, January 1, 2008; 29(1): 25 - 34. [Abstract] [Full Text] [PDF]